ANA Ana Hldgs

4 November 2024

ANANDA DEVELOPMENTS PLC 

("Ananda" or the "Company") 

Presentation at Aquis Showcase

Ananda Developments plc (AQSE: ANA), a Company focused on the development of CBD based therapies for the treatment of a range of complex inflammatory pain conditions, is pleased to announce that it will be presenting at the Aquis Stock Exchange Showcase on Tuesday 12th November in London, at the Royal College of Surgeons, WC2A 3PE.

Finance Director Jeremy Sturgess-Smith will deliver an eight-minute pitch, followed by a rapid-fire Q&A session to a live investor audience.

The event will provide an  opportunity to hear directly from the management team on the Company's pharmaceutical product development plans and to connect with them in person.

Investors interested in attending can register here with the code 'AQ20'.

-Ends-

To stay abreast of the latest developments at Ananda, follow our social media channels at:  

·              Investor Hub: investors.anandadevelopments.com

·              Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=   

·              LinkedIn: https://www.linkedin.com/company/anadevelopments/   

·              Twitter: https://twitter.com/AnandaPlc

·              Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor

-Ends-  

The Directors of the Company accept responsibility for the contents of this announcement.  

About Ananda Developments  

Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions.

For more information, please visit: https://anandadevelopments.com

https://investors.anandadevelopments.com/link/5PmQqP